Skip to main content
Premium Trial:

Request an Annual Quote

Abbott's Plan to Streamline Dx Business Topped Most-Read GenomeWeb Daily News Articles Last Week

NEW YORK (GenomeWeb News) - What are GenomeWeb Daily News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, Aug. 22.
 
1) Abbott to Streamline Dx Business, Cut Jobs (from Aug. 21)
 
2) NHGRI Awards $20M in Latest Round of Next-Gen Sequencing Grants (from Aug. 20)
 
3) Toronto University Group Collaborates with Thermo Fisher on Cancer Biomarker (from Aug. 18)
 
4) California Grants Navigenics, 23andMe Licenses to Offer Services in State (from Aug. 21)
 
5) Medco, FDA to Study Impact of Genetic Testing on Rx Efficacy (from Aug. 18)
 
 
The Scan

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.

Study Explores Animated Digital Message Approach to Communicate Genetic Test Results to Family Members

In the Journal of Genetic Counseling, the approach showed promise in participants presented with a hypothetical scenario related to a familial hereditary breast and ovarian cancer syndrome diagnosis.

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

A tool called Saluki, trained with mouse and human messenger RNA data, appears to improve mRNA half-life predictions by taking RNA and genetic features into account, a Genome Biology paper reports.

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.